(Q62392184)
Statements
A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer (English)
Giampietro Gasparini
Francesco Torino
Takayuki Ueno
Junichi Shishido
Akihiko Yoshizawa
Yukiko Mori
Satoshi Nagayama